Mesa Laboratories MLAB Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $3.63M+317% | $2.48M-27.8% | $4.74M+40.0% | -$7.11M+97.2% | ||
| $1.27M-6.6% | $1.27M+14.8% | $1.32M-13.4% | $1.4M0.0% | $1.35M+1.5% | ||
| $6.79M+116% | $3.38M+4.4% | $3.81M-0.7% | $3.88M+32.5% | $3.14M+12.4% | ||
| $4.13M+36.8% | —— | —— | -$3.44M+1.3% | $3.02M— | ||
| $974K+158% | —— | $766K+222% | $3.29M+390% | -$1.69M+27.9% | ||
| -$324K— | —— | -$1.21M— | $212K+155% | —— | ||
| $6.95M-27.3% | $5.05M+32.5% | -$2.58M-4.2% | -$5.93M-326% | $9.55M+959% | ||
| —— | -$1.26M+40.8% | -$1.63M-35.7% | -$1.25M-114% | -$1.03M— | ||
| —— | —— | -$813K-108% | $55K+106% | -$89K— | ||
| -$2.15M-15,229% | $715K+184% | -$1.61M-1,942% | $2.44M+440% | -$14K+99.8% | ||
| $4.49M-27.0% | $4.45M+1.2% | $4.53M-0.4% | $4.55M+12.1% | $6.14M+23.8% | ||
| $0— | -$0— | -$0— | -$0-100% | $0— | ||
| $13.96M+10.2% | $18.75M+3.4% | $8.22M+56.0% | $1.89M-82.4% | $12.67M-1.7% | ||
| $417K-44.9% | $732K-10.0% | $1.09M-38.9% | $1.01M+13.2% | $757K+41.5% | ||
| -$0-100% | -$0-100% | -$0-100% | -$0-100% | $62.5K— | ||
| -$417K+58.6% | -$732K+10.0% | -$1.09M+38.9% | -$1.01M-13.2% | -$1.01M— | ||
| $884K+1.6% | $884K+1.7% | $882K+1.8% | $873K+1.2% | $870K+0.7% | ||
| $14.69M-18.1% | $8.69M-8.0% | $5.94M-20.2% | $7.44M-21.2% | $17.94M+56.0% | ||
| -$15.76M+2.7% | -$9.79M+4.9% | -$7.88M+8.4% | -$8.43M+10.5% | -$16.19M— | ||
| $167K-81.4% | $316K— | $0-100% | $1.5M+958% | $900K+333% | ||
| -$2.05M+43.7% | $8.55M+29.2% | -$857K+79.3% | -$6.04M-2,442% | -$3.64M-36,250% | ||
| $4.49M-27.0% | $4.45M+1.2% | $4.53M-0.4% | $4.55M+12.1% | $6.14M+23.8% | ||
| $1.27M-6.6% | $1.27M+14.8% | $1.32M-13.4% | $1.4M0.0% | $1.35M+1.5% | ||
| —— | —— | $95K-97.4% | $5.99M+825% | —— | ||
| -$2.15M-15,229% | $715K+184% | -$1.61M-1,942% | $2.44M+440% | -$14K+99.8% | ||
| —— | $3.63M+317% | $2.48M-27.8% | $4.74M+40.0% | -$7.11M+97.2% | ||
| —— | -$1.26M+40.8% | -$1.63M-35.7% | -$1.25M-114% | -$1.03M— | ||
| -$0-100% | -$0-100% | -$0-100% | -$0-100% | $62.5K— | ||
| —— | -$214K— | -$564K-83.7% | -$1.06M-3.7% | —— | ||
| —— | —— | $97.5M— | -$0-100% | —— | ||
| $14.69M-18.1% | $8.69M-8.0% | $5.94M-20.2% | $7.44M-21.2% | $17.94M+56.0% | ||
| $0— | $0— | $0-100% | $0-100% | —— | ||
| $167K-81.4% | $316K— | $0-100% | $1.5M+958% | $900K+333% | ||
| —— | —— | -$813K-108% | $55K+106% | -$89K— | ||
| $2.39M— | $2.39M— | $2.39M— | $2.39M— | -$0— | ||
| —— | —— | $97M— | $10.5M-85.7% | —— | ||
| —— | —— | —— | —— | —— | ||
| $13.55M+13.7% | $18.02M+4.1% | $7.13M+105% | $884K-91.0% | $11.91M-3.6% | ||
| $13.55M+13.7% | $18.02M+4.1% | $7.13M+105% | $884K-91.0% | $11.91M-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mesa Laboratories generate?
- Mesa Laboratories (MLAB) generated $42.8M in operating cash flow over the trailing twelve months.
- What is Mesa Laboratories's free cash flow?
- After $3.3M of capital expenditures, Mesa Laboratories's free cash flow was $39.6M over the trailing twelve months, down 7.0% year over year.
- Where does Mesa Laboratories's cash flow data come from?
- Every line is extracted from Mesa Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
